Oncternal Therapeutics Inc Cash Flow Quality Index
Oncternal Therapeutics Inc cash flow quality index. Oncternal Therapeutics Inc (ONCT) has a Cash Flow Quality Index of -2.27x as of March 2016. Operating cash flow of $-4.78 Million is below net income of $2.11 Million, suggesting accrual-heavy earnings not yet converted to cash. See Oncternal Therapeutics Inc (ONCT) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Oncternal Therapeutics Inc (2010–2010)
Cash flow quality index of Oncternal Therapeutics Inc from 2010 to 2010. Historical Cash Flow Quality Index for Oncternal Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Oncternal Therapeutics Inc (ONCT) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Oncternal Therapeutics Inc Cash Flow Quality Index by Year (2010–2010)
Oncternal Therapeutics Inc cash flow quality index by year from 2010 to 2010. Year-by-year earnings quality comparison for Oncternal Therapeutics Inc. For the full cash flow conversion analysis, see Oncternal Therapeutics Inc cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2010 | -2.00x | $-30.53 Million | $15.29 Million | — |